GEORGE DEMETRION: Open Payments
NPI 1326048950 · PORTLAND, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,923 in 85 payments from 22 companies in 2025. Trend: 2023 $2,062 · 2024 $1,994 · 2025 $1,923
Food & beverage: $1,923
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $375 |
| ABBVIE INC. | 19 | $209 |
| Merck Sharp & Dohme LLC | 4 | $192 |
| PFIZER INC. | 5 | $191 |
| AstraZeneca Pharmaceuticals LP | 5 | $143 |
| Novartis Pharmaceuticals Corporation | 6 | $133 |
| Lilly USA, LLC | 7 | $128 |
| Aimmune Therapeutics, Inc. | 4 | $80 |
| ViiV Healthcare Company | 3 | $74 |
| GlaxoSmithKline, LLC. | 3 | $64 |
Products named: EVENITY, LEQVIO, CAPVAXIVE, QULIPTA, MOUNJARO, ZAVZPRET, ZENPEP, FARXIGA.
Industry payments across OR — which companies pay providers there.
